Class IIOngoing
SEASPINE ORTHOPEDICS CORPORATION recalls SeaSpine Polyaxial Head REF Number: 41-3010
Recall date · record updated Jul 29, 2026 · Source: U.S. Food and Drug Administration (openFDA device enforcement)
Check your product against the names and codes above. The FDA enforcement record lists the recall as voluntary: firm initiated; it does not state a consumer remedy, so follow the firm’s notice or the FDA link.
- Company
- SEASPINE ORTHOPEDICS CORPORATION
- Reason
- Due to manufacturing error, polyaxial head may popoff from the screw intraoperatively following insertion.
- Hazard
- FDA Class II: may cause temporary or medically reversible adverse health consequences (FDA definition).
- Who’s affected
- Worldwide - US Nationwide distribution including in the states of Alabama, Arizona, California, Colorado, Connecticut, Florida, Illinois, Indiana, Kansas, Maryland, Michigan, Missouri, Mississippi, Montana, Nevada, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, and Wyoming. The countries of Chile and Australia.
- Where
- Nationwide
- Official notice
- www.accessdata.fda.gov/scripts/ires/index.cfm?Event=99221…
Products
SeaSpine Polyaxial Head REF Number: 41-3010
Codes/lots: UDI: 10889981155117; Affected Lots: AW199682G, AW199684G.Quantity: 796 unitsRecall no. Z-2762-2026Class II
Update history
- First listed on OVERLOOKED from the official record.
When the agency expands or changes this recall, we update this page and log the change here.
Proof: raw official record (JSON) · fetched from FDA API
More Medicines & devices recalls
Medicines & devicesClass I
Par Health USA, LLC recalls 2 products
Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product solution.
· FDA · Nationwide
Medicines & devicesClass II
Right Value Drug Stores LLC recalls Testosterone Cypionate
Lack of sterility assurance.
· FDA · Nationwide
Medicines & devicesClass II
STRIDES PHARMA INC recalls Cinacalcet Tablets
Failed dissolution specifications
· FDA · Nationwide